H L Storr1, R Prasad2, I K Temple3, L A Metherell2, M O Savage2, J M Walker4. 1. Centre for Endocrinology, John Vane Science Centre, William Harvey Research Institute (WHRI), Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. h.l.storr@qmul.ac.uk. 2. Centre for Endocrinology, John Vane Science Centre, William Harvey Research Institute (WHRI), Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. 3. Faculty of Medicine, University of Southampton, Southampton, UK. 4. Department of Paediatric Endocrinology, Portsmouth Hospitals National Health Service Trust, Portsmouth, UK.
Abstract
PURPOSE: The IGFALS gene encodes the acid-labile subunit (ALS) protein, which regulates circulating IGF-1. Human IGFALS mutations cause growth hormone insensitivity (GHI) associated with ALS, IGF-1 and IGFBP-3 deficiencies and mild to moderate postnatal growth impairment (height SDS -2 to -4). Prenatal growth impairment is not a recognised feature of this disorder, but heterozygous carriers may show an intermediate phenotype. METHODS: We report a family of five subjects, including three children born small for gestational age, who were investigated for IGFALS gene mutations. RESULTS: The proband, an 8.7 years female with pre- and postnatal growth failure (BW SDS -3.04, Ht SDS -3.86) and biochemical features of GHI, had a homozygous mutation of IGFALS, c.401T>A; p.L134Q. Her 6.1 years brother (BW SDS -2.11, Ht SDS -2.0) had the same homozygous IGFALS mutation. Both parents [adult height SDS -1.76 (father) and -1.82 (mother)] and her 2.7 years sister (BW SDS -2.60, Ht SDS -2.04) were heterozygous for the IGFALS mutation. CONCLUSION: Significant phenotypic heterogeneity was observed between family members, in particular varying degrees of prenatal growth retardation were present in the three siblings, which may have contributed to the variation in the postnatal growth phenotype.
PURPOSE: The IGFALS gene encodes the acid-labile subunit (ALS) protein, which regulates circulating IGF-1. Human IGFALS mutations cause growth hormone insensitivity (GHI) associated with ALS, IGF-1 and IGFBP-3 deficiencies and mild to moderate postnatal growth impairment (height SDS -2 to -4). Prenatal growth impairment is not a recognised feature of this disorder, but heterozygous carriers may show an intermediate phenotype. METHODS: We report a family of five subjects, including three children born small for gestational age, who were investigated for IGFALS gene mutations. RESULTS: The proband, an 8.7 years female with pre- and postnatal growth failure (BW SDS -3.04, Ht SDS -3.86) and biochemical features of GHI, had a homozygous mutation of IGFALS, c.401T>A; p.L134Q. Her 6.1 years brother (BW SDS -2.11, Ht SDS -2.0) had the same homozygous IGFALS mutation. Both parents [adult height SDS -1.76 (father) and -1.82 (mother)] and her 2.7 years sister (BW SDS -2.60, Ht SDS -2.04) were heterozygous for the IGFALS mutation. CONCLUSION: Significant phenotypic heterogeneity was observed between family members, in particular varying degrees of prenatal growth retardation were present in the three siblings, which may have contributed to the variation in the postnatal growth phenotype.
Entities:
Keywords:
Acid-labile subunit (ALS); Growth hormone insensitivity (GHI); IGFALS mutation; Short stature; Small for gestational age (SGA)
Authors: Horacio M Domené; Sonia V Bengolea; Alicia S Martínez; M Gabriela Ropelato; Patricia Pennisi; Paula Scaglia; Juan J Heinrich; Héctor G Jasper Journal: N Engl J Med Date: 2004-02-05 Impact factor: 91.245
Authors: Germán Iñiguez; Felipe Argandoña; Pablo Medina; Carolina González; Sebastián San Martín; Elena Kakarieka; M Cecilia Johnson; Fernando Cassorla Journal: J Clin Endocrinol Metab Date: 2010-10-13 Impact factor: 5.958
Authors: H A van Duyvenvoorde; M J E Kempers; Th B Twickler; J van Doorn; W J Gerver; C Noordam; M Losekoot; M Karperien; J M Wit; A R M M Hermus Journal: Eur J Endocrinol Date: 2008-05-07 Impact factor: 6.664
Authors: Horacio M Domené; Vivian Hwa; Jesús Argente; Jan M Wit; Jaan M Wit; Cecilia Camacho-Hübner; Héctor G Jasper; Jesús Pozo; Hermine A van Duyvenvoorde; Shoshana Yakar; Olga V Fofanova-Gambetti; Ron G Rosenfeld Journal: Horm Res Date: 2009-09-01
Authors: Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa Journal: Endocr Rev Date: 2019-04-01 Impact factor: 19.871
Authors: Werner F Blum; Abdullah Alherbish; Afaf Alsagheir; Ahmed El Awwa; Walid Kaplan; Ekaterina Koledova; Martin O Savage Journal: Endocr Connect Date: 2018-05-03 Impact factor: 3.335